A metabolite detected in postmortem blood need not have been detectable in that blood at death. In a controlled pig experiment, HO-RCS-4 was not detected in perimortem blood but appeared in some blood specimens after room-temperature storage. The result demonstrated a postmortem change in detectability, without proving one mechanism or establishing when a human used the parent drug.
The experiment controlled administration and death timing
Schaefer and colleagues gave twelve male pigs pulmonary doses of JWH-210, RCS-4 and THC, each at 200 µg/kg body weight, using an ultrasonic nebulizer. The animals were anesthetized and mechanically ventilated. Eight hours after administration, they were euthanized and initial specimens were collected.
Six carcasses were stored at room temperature and six at 4°C. Further collections occurred at 24, 48 and 72 hours after death. These were known experimental intervals, unlike the frequently uncertain timelines in human autopsy cases.
The peripheral specimen site changed
The initial peripheral blood came from the jugular vein. Later peripheral collections came from the femoral or brachiocephalic vein. Central blood and numerous tissues and fluids were also sampled. Collected specimens were stored at −20°C pending analysis.
Changing peripheral collection sites limited interpretation as a pure same-site time course. The abdominal cavity was opened for sampling and sutured afterward; the authors acknowledged that opening could alter microbial conditions and decomposition, especially at room temperature.
What was observed for HO-RCS-4?
HO-RCS-4, a hydroxylated RCS-4 metabolite, was not detected in peripheral or central blood at the initial collection. In the room-temperature group it was subsequently detected in peripheral blood from some animals, with the timing of detection varying between pigs, and in central blood from four pigs.
In the positive peripheral specimens, concentrations increased from 24 to 72 hours. Central-blood concentrations increased to 48 hours and then decreased. In contrast, HO-RCS-4 was not detected in postmortem peripheral or central blood in the 4°C group. The result was not universal across animals, time points or storage conditions.
Analytical sensitivity belongs with the finding
The blood LC–MS/MS method had a reported HO-RCS-4 detection limit of 0.15 ng/mL and lower quantification limit of 0.5 ng/mL. A nondetection was bounded by that method’s sensitivity; it did not establish that absolutely no metabolite was present.
The study separately quantified tissues and bile/duodenal material using standard addition after enzymatic cleavage and extraction. Concentrations from those processed matrices should not be silently equated with free-metabolite concentrations in blood.
What could explain the appearance?
The authors proposed redistribution from neighboring tissues or release of free HO-RCS-4 from glucuronide through postmortem hydrolysis. Those were possible explanations. The experiment did not directly apportion the observed blood increase between those mechanisms.
HO-RCS-4 was the most prevalent metabolite in the investigated postmortem material, but that did not make its blood concentration a validated intake clock. The study also showed substantial variability and warned against overinterpreting concentration changes.
Implications for human casework
The experiment supports caution when treating a postmortem parent/metabolite pattern as unchanged from life. It did not establish a human concentration cutoff, dose conversion, impairment measure or cause-of-death criterion. The controlled co-administration, anesthesia, species and sampling procedures all restrict transfer to an individual human death.
For another metabolite-attribution issue, see why clonazepam metabolites do not uniquely establish clonazafone exposure.
Primary source
Schaefer N, Kröll AK, Körbel C, et al. Time- and temperature-dependent postmortem concentration changes of the (synthetic) cannabinoids JWH-210, RCS-4, as well as Δ9-tetrahydrocannabinol following pulmonary administration to pigs. Archives of Toxicology. 2020;94:1585–1599. doi:10.1007/s00204-020-02707-4.
Leave a Reply